Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ASH 2018
Pharma
Too many drugs will vie for market share in 15 diseases: report
Leerink analysts predict a doubling of competitive intensity in 15 disease areas by 2023, putting a dozen companies at risk.
Arlene Weintraub
Dec 13, 2018 12:00pm
AZ's Calquence found success in MCL. Will CLL follow?
Dec 5, 2018 11:13am
J&J makes Xarelto case for clot prevention in cancer
Dec 4, 2018 10:30am
J&J's fast-growing Darzalex lines up for 2nd 1L myeloma nod
Dec 4, 2018 10:30am
J&J, AbbVie's Imbruvica steals CLL spotlight with phase 3 wins
Dec 4, 2018 10:11am
Seattle Genetics' Adcetris posts double survival win
Dec 3, 2018 9:15pm
